COLLATERAL RELEASE AND NONDISTURBANCE AGREEMENTCollateral Release and Nondisturbance Agreement • January 2nd, 2004 • Women First Healthcare Inc • Wholesale-drugs, proprietaries & druggists' sundries • New York
THIS COLLATERAL RELEASE AND NONDISTURBANCE AGREEMENT dated as of December 17, 2003 (this “Agreement”) is made by and among WOMEN FIRST HEALTHCARE, INC. (“WFHC”), SHIRE PHARMACEUTICALS IRELAND LIMITED (“Shire”), CIBC WMC INC., in its capacity as Collateral Agent and acting on its own behalf and on behalf of the other Secured Parties under that certain Amended and Restated Security Agreement dated as of May 12, 2003 (“CIBC”), and the Required Holders (as defined below).
LICENSE AND SUPPLY AGREEMENT between WOMEN FIRST HEALTHCARE, INC. and SHIRE PHARMACEUTICALS IRELAND LIMITED for CERTAIN INTERNATIONAL RIGHTS TO VANIQA® (EFLORNITHINE HYDROCHLORIDE) CREAM Dated as of December 15, 2003License and Supply Agreement • January 2nd, 2004 • Women First Healthcare Inc • Wholesale-drugs, proprietaries & druggists' sundries • New York
THIS LICENSE AND SUPPLY AGREEMENT (this “Agreement”), dated as of December 15, 2003 (the “Effective Date”), is between WOMEN FIRST HEALTHCARE, INC., a Delaware corporation (“WFHC”), and SHIRE PHARMACEUTICALS IRELAND LIMITED, a company incorporated in Ireland, registered number 349143 whose registered office is at 6 Fitzwilliam Square, Dublin 2, Ireland (“Shire”).
